Biblio

Author Title [ Type

] Year

Filters: Author is Klausz, Katja [Clear All Filters]

Journal Article

Kellner C, Lutz S, Oberg H-H, Wesch D, Otte A, Diemer KJ, Wilcken H, Bauerschlag D, Glüer C-C, Wichmann C, et al. Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen. Biol Chem. 2021.

Khodoun MV, Morris SC, Shao W-H, Potter C, Angerman E, Kiselev A, Yarawsky AE, Herr AB, Klausz K, Otte A, et al. Suppression of IgE-mediated anaphylaxis and food allergy with monovalent anti-FcεRIα monoclonal antibodies. J Allergy Clin Immunol. 2020.

Kellner C, Derer S, Klausz K, Rosskopf S, Wirt T, Rosner T, Otte A, Cappuzzello E, Peipp M. Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC Activity. Methods Mol Biol. 2018;1827:381-397.

Baumann N, Rosner T, Jansen JHMarco, Chan C, Eichholz KMarie, Klausz K, Winterberg D, Müller K, Humpe A, Burger R, et al. Enhancement of EGFR antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/SIRPα interactions. Cancer Sci. 2021.

Sahin M, Remy MM, Fallet B, Sommerstein R, Florova M, Langner A, Klausz K, Straub T, Kreutzfeldt M, Wagner I, et al. Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors. Cell Rep. 2022;38(5):110303.

Zielonka S, Krah S, Arras P, Lipinski B, Zimmermann J, Boje ASvea, Klausz K, Peipp M, Pekar L. Affinity Maturation of the Natural Ligand (B7-H6) for Natural Cytotoxicity Receptor NKp30 by Yeast Surface Display. Methods Mol Biol. 2023;2681:231-248.